Psyence Biomedical Stock Forward View - Simple Exponential Smoothing
| PBM Stock | USD 0.72 0.05 6.49% |
Psyence Stock outlook is based on your current time horizon.
The value of RSI of Psyence Biomedical's share price is below 30 as of now indicating that the stock is becoming oversold or undervalued. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling Psyence Biomedical Ltd, making its price go up or down. Momentum 21
Sell Stretched
Oversold | Overbought |
Using Psyence Biomedical hype-based prediction, you can estimate the value of Psyence Biomedical Ltd from the perspective of Psyence Biomedical response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Exponential Smoothing forecasted value of Psyence Biomedical Ltd on the next trading day is expected to be 0.72 with a mean absolute deviation of 0.63 and the sum of the absolute errors of 38.55. Psyence Biomedical after-hype prediction price | USD 0.72 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Psyence Biomedical to cross-verify your projections. Psyence Biomedical Additional Predictive Modules
Most predictive techniques to examine Psyence price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Psyence using various technical indicators. When you analyze Psyence charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Psyence Biomedical Simple Exponential Smoothing Price Forecast For the 31st of January
Given 90 days horizon, the Simple Exponential Smoothing forecasted value of Psyence Biomedical Ltd on the next trading day is expected to be 0.72 with a mean absolute deviation of 0.63, mean absolute percentage error of 1.43, and the sum of the absolute errors of 38.55.Please note that although there have been many attempts to predict Psyence Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Psyence Biomedical's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Psyence Biomedical Stock Forecast Pattern
| Backtest Psyence Biomedical | Psyence Biomedical Price Prediction | Buy or Sell Advice |
Psyence Biomedical Forecasted Value
In the context of forecasting Psyence Biomedical's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Psyence Biomedical's downside and upside margins for the forecasting period are 0.01 and 15.18, respectively. We have considered Psyence Biomedical's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Psyence Biomedical stock data series using in forecasting. Note that when a statistical model is used to represent Psyence Biomedical stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 118.4687 |
| Bias | Arithmetic mean of the errors | 0.312 |
| MAD | Mean absolute deviation | 0.632 |
| MAPE | Mean absolute percentage error | 0.1579 |
| SAE | Sum of the absolute errors | 38.55 |
Predictive Modules for Psyence Biomedical
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Psyence Biomedical. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Psyence Biomedical After-Hype Price Density Analysis
As far as predicting the price of Psyence Biomedical at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Psyence Biomedical or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Psyence Biomedical, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Psyence Biomedical Estimiated After-Hype Price Volatility
In the context of predicting Psyence Biomedical's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Psyence Biomedical's historical news coverage. Psyence Biomedical's after-hype downside and upside margins for the prediction period are 0.04 and 15.06, respectively. We have considered Psyence Biomedical's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Psyence Biomedical is out of control at this time. Analysis and calculation of next after-hype price of Psyence Biomedical is based on 3 months time horizon.
Psyence Biomedical Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Psyence Biomedical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Psyence Biomedical backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Psyence Biomedical, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
3.23 | 14.46 | 0.61 | 0.07 | 3 Events / Month | 6 Events / Month | In about 3 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.72 | 0.72 | 0.00 |
|
Psyence Biomedical Hype Timeline
On the 30th of January Psyence Biomedical is traded for 0.72. The entity has historical hype elasticity of -0.61, and average elasticity to hype of competition of 0.07. Psyence is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is at this time at -3.23%. %. The volatility of related hype on Psyence Biomedical is about 62869.57%, with the expected price after the next announcement by competition of 0.79. The company has price-to-book ratio of 0.07. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Psyence Biomedical recorded a loss per share of 62.4. The entity had not issued any dividends in recent years. The firm had 16:100 split on the 20th of January 2026. Considering the 90-day investment horizon the next forecasted press release will be in about 3 days. Check out Historical Fundamental Analysis of Psyence Biomedical to cross-verify your projections.Psyence Biomedical Related Hype Analysis
Having access to credible news sources related to Psyence Biomedical's direct competition is more important than ever and may enhance your ability to predict Psyence Biomedical's future price movements. Getting to know how Psyence Biomedical's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Psyence Biomedical may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| AZTR | Azitra Inc | 0.00 | 7 per month | 0.00 | (0.15) | 7.14 | (11.36) | 34.09 | |
| NKGN | NKGen Biotech Common | 0.00 | 0 per month | 0.00 | 0.21 | 20.00 | (6.00) | 68.90 | |
| GTBP | GT Biopharma | (0.07) | 8 per month | 6.74 | 0.03 | 10.84 | (10.45) | 51.03 | |
| REVB | Revelation Biosciences | (0.12) | 11 per month | 0.00 | (0.26) | 5.56 | (9.09) | 35.57 | |
| PTIX | Protagenic Therapeutics | 0.15 | 7 per month | 0.00 | (0.20) | 14.81 | (15.25) | 58.73 | |
| LIPO | Lipella Pharmaceuticals Common | 0.33 | 28 per month | 0.00 | (0.14) | 17.07 | (16.00) | 44.95 | |
| ELAB | Elevai Labs Common | 0.64 | 3 per month | 0.00 | (0.40) | 5.71 | (14.29) | 38.62 | |
| SPRC | Scisparc | (0.19) | 8 per month | 0.00 | (0.42) | 3.57 | (12.20) | 30.69 | |
| DRMA | Dermata Therapeutics | (0.32) | 10 per month | 0.00 | (0.05) | 16.18 | (12.50) | 58.17 | |
| INDP | Indaptus Therapeutics | (0.19) | 6 per month | 0.00 | (0.06) | 13.58 | (12.56) | 51.64 |
Other Forecasting Options for Psyence Biomedical
For every potential investor in Psyence, whether a beginner or expert, Psyence Biomedical's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Psyence Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Psyence. Basic forecasting techniques help filter out the noise by identifying Psyence Biomedical's price trends.Psyence Biomedical Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Psyence Biomedical stock to make a market-neutral strategy. Peer analysis of Psyence Biomedical could also be used in its relative valuation, which is a method of valuing Psyence Biomedical by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Psyence Biomedical Market Strength Events
Market strength indicators help investors to evaluate how Psyence Biomedical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Psyence Biomedical shares will generate the highest return on investment. By undertsting and applying Psyence Biomedical stock market strength indicators, traders can identify Psyence Biomedical Ltd entry and exit signals to maximize returns.
| Accumulation Distribution | 49568.67 | |||
| Daily Balance Of Power | (0.33) | |||
| Rate Of Daily Change | 0.94 | |||
| Day Median Price | 0.76 | |||
| Day Typical Price | 0.74 | |||
| Price Action Indicator | (0.06) | |||
| Period Momentum Indicator | (0.05) | |||
| Relative Strength Index | 21.92 |
Psyence Biomedical Risk Indicators
The analysis of Psyence Biomedical's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Psyence Biomedical's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting psyence stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 7.64 | |||
| Standard Deviation | 14.34 | |||
| Variance | 205.58 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Psyence Biomedical
The number of cover stories for Psyence Biomedical depends on current market conditions and Psyence Biomedical's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Psyence Biomedical is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Psyence Biomedical's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Psyence Biomedical Short Properties
Psyence Biomedical's future price predictability will typically decrease when Psyence Biomedical's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Psyence Biomedical Ltd often depends not only on the future outlook of the potential Psyence Biomedical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Psyence Biomedical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 568 K | |
| Cash And Short Term Investments | 6.1 M |
Check out Historical Fundamental Analysis of Psyence Biomedical to cross-verify your projections. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Will Stock sector continue expanding? Could Psyence diversify its offerings? Factors like these will boost the valuation of Psyence Biomedical. Anticipated expansion of Psyence directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Psyence Biomedical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Psyence Biomedical's market price often diverges from its book value, the accounting figure shown on Psyence's balance sheet. Smart investors calculate Psyence Biomedical's intrinsic value—its true economic worth—which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Psyence Biomedical's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Psyence Biomedical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Psyence Biomedical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Psyence Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.